So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process to produce pharmaceutical-grade proteins in a matter of ...
It is made by introducing genes of the virus into leaf cells of Nicotiana genus plants ... the officials said. Medicago signed an agreement to sell 76 million doses of the vaccine to the Canadian ...